GL1X · GenesisL1 explorer

UniProt Q00535

Cyclin-dependent-like kinase 5 (Q00535)

Cyclin-dependent-like kinase 5 (UniProt Q00535), EC 2.7.11.1: 19 experimental structures and 1 predicted model on GenesisL1, 5 ligands bound, 24 pockets. Binding sites, druggability and experiment against prediction (TM-score) in…

UniProt
Q00535
Protein
Cyclin-dependent-like kinase 5
EC
2.7.11.1
Experimental structures
19
Predicted models
1
Ligands
5
Pockets
24 · 2 records with a druggable one

Structures

20 records of Q00535 in the MolNFT archive: 19 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
1H4LStructure and regulation of the CDK5-p25(nck5a) complexx-ray diffractionA, B——
1H4LStructure and regulation of the CDK5-P25(NCK5A) complexx-ray diffractionA, B——
1UNGStructural mechanism for the inhibition of CDK5-p25 by roscovitine, aloisine and indirubin.x-ray diffractionA, B——
1UNGStructural mechanism for the inhibition of CDK5-P25 by roscovitine, aloisine and indirubin.x-ray diffractionA, B——
1UNHStructural mechanism for the inhibition of CDK5-p25 by roscovitine, aloisine and indirubin.x-ray diffractionA, B——
1UNHStructural mechanism for the inhibition of CDK5-P25 by roscovitine, aloisine and indirubin.x-ray diffractionA, B——
1UNLStructural mechanism for the inhibition of CD5-p25 from the roscovitine, aloisine and indirubin.x-ray diffractionA, B——
1UNLStructural mechanism for the inhibition of CD5-P25 from the roscovitine, aloisine and indirubin.x-ray diffractionA, B——
3O0GCrystal Structure of Cdk5:p25 in complex with an ATP analoguex-ray diffractionA, B——
3O0GCrystal structure of CDK5:P25 in complex with an ATP analoguex-ray diffractionA, B——
4AU8Crystal structure of compound 4a in complex with cdk5, showing an unusual binding mode to the hinge…x-ray diffractionA, B——
4AU8Crystal structure of compound 4A in complex with CDK5, showing an unusual binding mode to the hinge…x-ray diffractionA, B——
7VDPThe structure of cyclin-dependent kinase 5 (CDK5) in complex with P25 and compound 1x-ray diffractionA, B65L, CL—
7VDQThe structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 7x-ray diffractionA, B64V13 (best 0.77)
7VDQThe structure of cyclin-dependent kinase 5 (CDK5) in complex with P25 and compound 7x-ray diffractionA, B64V—
7VDRThe structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 13x-ray diffractionA, B63I11 (best 0.75)
7VDRThe structure of cyclin-dependent kinase 5 (CDK5) in complex with P25 and compound 13x-ray diffractionA, B63I—
7VDSThe structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 24x-ray diffractionA, B61U, CL—
7VDSThe structure of cyclin-dependent kinase 5 (CDK5) in complex with P25 and compound 24x-ray diffractionA, B61U, CL—
Q00535AlphaFold monomer V2.0 prediction for cyclin-dependent-like kinase 5 (Q00535)predictedA——

Ligands

  • CL · Chloride ion · in 3 records
  • 61U · 5-fluoranyl-4-[[2-[(1R)-1-(1-methylpiperidin-4-yl)-1-oxidanyl-ethyl]-1,6-naphthyridin-7-yl]amino]-2-morpholin-4-yl-benzenecarbonitrile · in 2 records
  • 63I · (1R)-1-[7-[(2-fluoranyl-4-pyrazol-1-yl-phenyl)amino]-1, 6-naphthyridin-2-yl]-1-(1-methylpiperidin-4-yl)ethanol · in 2 records
  • 64V · 2-[[7-[[2-fluoranyl-4-[3-(hydroxymethyl)pyrazol-1-yl]phenyl]amino]-1,6-naphthyridin-2-yl]-(1-methylpiperidin-4-yl)amino]ethanoic acid · in 2 records
  • 65L · [1-[3-fluoranyl-4-[(2-piperidin-4-yloxy-1,6-naphthyridin-7-yl)amino]phenyl]pyrazol-3-yl]methanol · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.